Tomas J. Heyman
Director · 2 filings · Latest: Sep 24, 2026
EXELIXIS, INC.
Legend Biotech Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
EXEL | Heyman Tomas J. | — | May 21, 2025 | Proposed Sale | $44.29 | 4,544 | $201.3K | — | |
LEGN | Heyman Tomas J. | — | Dec 2, 2024 | Proposed Sale | $43.31 | 4,366 | $189.1K | — | |